Published in Clinical Oncology Week, November 22nd, 2004
The data were presented at the XV International Symposium on Drugs Affecting Lipid Metabolism (DALM) in Venice, Italy.
Results from direct Statin comparison of LDL-C values: an evaluation of rosuvastatin LDL therapy (DISCOVERY), presented for the first time, show that CRESTOR, at the usual start dose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.